Activated T cells and soluble molecules in the portal venous blood of patients with cholestatic and hepatitis C virus-positive liver cirrhosis. Possible promotion of Fas/FasL-mediated apoptosis in the bile-duct cells and hepatocyte injury

N. Ariki, Y. Morimoto, Takahito Yagi, T. Oyama, Y. Cyouda, H. Sadamori, M. Inagaki, N. Urushihara, H. Iwagaki, N. Tanaka

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

We investigated the immune responses of patients with cholestatic and hepatitis C virus-positive (HCV-positive) liver cirrhosis by analysing T-cell subsets and cytokine levels in the portal and peripheral veins, using flow cytometry and enzyme-linked immunosorbent assay. In cholestatic liver cirrhosis, the proportion of natural-killer (NK) T cells and interleukin (IL) 6 and IL-18 levels in the portal venous blood were significantly higher than those in the peripheral venous blood. In HCV-positive liver cirrhosis, the proportions of NK T cells and Fas+ T cells and IL-6 and soluble Fas levels in the portal venous blood were significantly higher than those in the peripheral venous blood. These results suggest that in these diseases, activated T cells and soluble molecules in portal venous blood may promote Fas/FasL-mediated apoptosis of the bile-duct cells and hepatocytes, and contribute to the deterioration in liver function as an inevitable result of positive feedback.

Original languageEnglish
Pages (from-to)170-180
Number of pages11
JournalJournal of International Medical Research
Volume31
Issue number3
Publication statusPublished - May 2003

Fingerprint

T-cells
Bile Ducts
Viruses
Hepacivirus
Liver Cirrhosis
Liver
Ducts
Hepatocytes
Blood
Apoptosis
T-Lymphocytes
Molecules
Wounds and Injuries
Natural Killer T-Cells
Interleukin-6
Immunosorbents
Interleukin-18
Flow cytometry
T-Lymphocyte Subsets
Portal Vein

Keywords

  • Apoptosis
  • Cholestatic liver cirrhosis
  • Fas
  • Fas-ligand
  • HCV-positive liver cirrhosis
  • Interleukin 18
  • Interleukin 6
  • Natural-killer T cells

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Activated T cells and soluble molecules in the portal venous blood of patients with cholestatic and hepatitis C virus-positive liver cirrhosis. Possible promotion of Fas/FasL-mediated apoptosis in the bile-duct cells and hepatocyte injury. / Ariki, N.; Morimoto, Y.; Yagi, Takahito; Oyama, T.; Cyouda, Y.; Sadamori, H.; Inagaki, M.; Urushihara, N.; Iwagaki, H.; Tanaka, N.

In: Journal of International Medical Research, Vol. 31, No. 3, 05.2003, p. 170-180.

Research output: Contribution to journalArticle

@article{2b04531f4bf84b75a6ee170cd38b38cc,
title = "Activated T cells and soluble molecules in the portal venous blood of patients with cholestatic and hepatitis C virus-positive liver cirrhosis. Possible promotion of Fas/FasL-mediated apoptosis in the bile-duct cells and hepatocyte injury",
abstract = "We investigated the immune responses of patients with cholestatic and hepatitis C virus-positive (HCV-positive) liver cirrhosis by analysing T-cell subsets and cytokine levels in the portal and peripheral veins, using flow cytometry and enzyme-linked immunosorbent assay. In cholestatic liver cirrhosis, the proportion of natural-killer (NK) T cells and interleukin (IL) 6 and IL-18 levels in the portal venous blood were significantly higher than those in the peripheral venous blood. In HCV-positive liver cirrhosis, the proportions of NK T cells and Fas+ T cells and IL-6 and soluble Fas levels in the portal venous blood were significantly higher than those in the peripheral venous blood. These results suggest that in these diseases, activated T cells and soluble molecules in portal venous blood may promote Fas/FasL-mediated apoptosis of the bile-duct cells and hepatocytes, and contribute to the deterioration in liver function as an inevitable result of positive feedback.",
keywords = "Apoptosis, Cholestatic liver cirrhosis, Fas, Fas-ligand, HCV-positive liver cirrhosis, Interleukin 18, Interleukin 6, Natural-killer T cells",
author = "N. Ariki and Y. Morimoto and Takahito Yagi and T. Oyama and Y. Cyouda and H. Sadamori and M. Inagaki and N. Urushihara and H. Iwagaki and N. Tanaka",
year = "2003",
month = "5",
language = "English",
volume = "31",
pages = "170--180",
journal = "Journal of International Medical Research",
issn = "0300-0605",
publisher = "Field House Publishing LLP",
number = "3",

}

TY - JOUR

T1 - Activated T cells and soluble molecules in the portal venous blood of patients with cholestatic and hepatitis C virus-positive liver cirrhosis. Possible promotion of Fas/FasL-mediated apoptosis in the bile-duct cells and hepatocyte injury

AU - Ariki, N.

AU - Morimoto, Y.

AU - Yagi, Takahito

AU - Oyama, T.

AU - Cyouda, Y.

AU - Sadamori, H.

AU - Inagaki, M.

AU - Urushihara, N.

AU - Iwagaki, H.

AU - Tanaka, N.

PY - 2003/5

Y1 - 2003/5

N2 - We investigated the immune responses of patients with cholestatic and hepatitis C virus-positive (HCV-positive) liver cirrhosis by analysing T-cell subsets and cytokine levels in the portal and peripheral veins, using flow cytometry and enzyme-linked immunosorbent assay. In cholestatic liver cirrhosis, the proportion of natural-killer (NK) T cells and interleukin (IL) 6 and IL-18 levels in the portal venous blood were significantly higher than those in the peripheral venous blood. In HCV-positive liver cirrhosis, the proportions of NK T cells and Fas+ T cells and IL-6 and soluble Fas levels in the portal venous blood were significantly higher than those in the peripheral venous blood. These results suggest that in these diseases, activated T cells and soluble molecules in portal venous blood may promote Fas/FasL-mediated apoptosis of the bile-duct cells and hepatocytes, and contribute to the deterioration in liver function as an inevitable result of positive feedback.

AB - We investigated the immune responses of patients with cholestatic and hepatitis C virus-positive (HCV-positive) liver cirrhosis by analysing T-cell subsets and cytokine levels in the portal and peripheral veins, using flow cytometry and enzyme-linked immunosorbent assay. In cholestatic liver cirrhosis, the proportion of natural-killer (NK) T cells and interleukin (IL) 6 and IL-18 levels in the portal venous blood were significantly higher than those in the peripheral venous blood. In HCV-positive liver cirrhosis, the proportions of NK T cells and Fas+ T cells and IL-6 and soluble Fas levels in the portal venous blood were significantly higher than those in the peripheral venous blood. These results suggest that in these diseases, activated T cells and soluble molecules in portal venous blood may promote Fas/FasL-mediated apoptosis of the bile-duct cells and hepatocytes, and contribute to the deterioration in liver function as an inevitable result of positive feedback.

KW - Apoptosis

KW - Cholestatic liver cirrhosis

KW - Fas

KW - Fas-ligand

KW - HCV-positive liver cirrhosis

KW - Interleukin 18

KW - Interleukin 6

KW - Natural-killer T cells

UR - http://www.scopus.com/inward/record.url?scp=10744226853&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=10744226853&partnerID=8YFLogxK

M3 - Article

VL - 31

SP - 170

EP - 180

JO - Journal of International Medical Research

JF - Journal of International Medical Research

SN - 0300-0605

IS - 3

ER -